NF-κB inhibitor SC75741, Purity ≥98%

Cat. No.: X23-10-ZQ773

NF-κB inhibitor SC75741, Purity ≥98%

Synonym: SC75741; 913822-46-5; N-(6-Benzoyl-1H-benzimidazol-2-yl)-2-(1-thieno[3,2-d]pyrimidin-4-yl-4-piperidinyl)-4-Thiazolecarboxamide; SC-75741; N-(6-Benzoyl-1H-benzimidazol-2-yl)-2-(1-thieno[3,2-d]pyrimidin-4-yl-4-piperidinyl)-4-thiazolecarboxamide; N-(6-Benzoyl-1H-benzo[d]imidazol-2-yl)-2-(1-(thieno[3,2-d]pyrimidin-4-yl)piperidin-4-yl)thiazole-4-carboxamide; NF-κB inhibitor

  • CAS Number: 913822-46-5
  • Compound CID: 23661638
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
SC75741, soluble in warmed DMSO and insoluble in water and ethanol, is a potent and specific inhibitor of NF-κB activation. It targets NFκB.
Molecular Weight
565.67
Molecular Formula
C29H23N7O2S2
Targets
NFκB: 200 nM (EC50)
Form
Lyophilized powder
Purity
≥98%
Solubility
Warmed DMSO: 35 mg/mL (61.87 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
SC75741 can be used to investigate its role as an NF-κB inhibitor in various inflammatory and autoimmune disease models.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0